The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy

Por Moran, Amy E., Kovacsovics-Bankowski, Magdalena, Weinberg, Andrew D.
Publicado em 2013

Science gone translational: the OX40 agonist story

Por Weinberg, Andrew D., Morris, Nicholas P., Kovacsovics-Bankowski, Magdalena, Urba, Walter J., Curti, Brendan D.
Publicado em 2011

Phase I/II clinical trial of anti-OX40, radiation and cyclophosphamide in patients with prostate cancer: immunological analysis

Por Kovacsovics-Bankowski, Magdalena, Chisholm, Lana, Vercellini, Jonna, Crittenden, Marka, Lary, Scot, Curti, Brendan, Weinberg, Andrew
Publicado em 2013

A detailed characterization of peripheral blood lymphocytes in patients with myeloproliferative disease treated with pegylated-interferon alpha

Por Kovacsovics-Bankowski, Magdalena, Warby, Christy, Effimova, Olga, Kelley, Todd W, Kim, Soo, Swierczek, Sabina, Prchal, Josef
Publicado no J Immunother Cancer (2015)

Changes in peripheral blood lymphocytes in polycythemia vera and essential thrombocythemia patients treated with pegylated-interferon alpha and correlation with JAK2(V617F) allelic...

Por Kovacsovics-Bankowski, Magdalena, Kelley, Todd W., Efimova, Olga, Kim, Soo Jin, Wilson, Andrew, Swierczek, Sabina, Prchal, Josef
Publicado no Exp Hematol Oncol (2016)

Two Adjacent Trimeric Fas Ligands Are Required for Fas Signaling and Formation of a Death-Inducing Signaling Complex

Por Holler, Nils, Tardivel, Aubry, Kovacsovics-Bankowski, Magdalena, Hertig, Sylvie, Gaide, Olivier, Martinon, Fabio, Tinel, Antoine, Deperthes, David, Calderara, Silvio, Schulthess, Therese, Engel, Jürgen, Schneider, Pascal, Tschopp, Jürg
Publicado em 2003

CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myeloma

Por Yousef, Sara, Kovacsovics-Bankowski, Magdalena, Salama, Mohamed E, Bhardwaj, Neelam, Steinbach, Mary, Langemo, Amanda, Kovacsovics, Tibor, Marvin, James, Binder, Mascha, Panse, Jens, Kröger, Nicolaus, Luetkens, Tim, Atanackovic, Djordje
Publicado no Hum Vaccin Immunother (2015)

Detailed characterization of tumor infiltrating lymphocytes in two distinct human solid malignancies show phenotypic similarities

Por Kovacsovics-Bankowski, Magdalena, Chisholm, Lana, Vercellini, Jonna, Tucker, Christopher G, Montler, Ryan, Haley, Daniel, Newell, Philippa, Ma, Jun, Tseng, Paul, Wolf, Ronald, Vetto, John T, Hammill, Chet, Hansen, Paul, Weinberg, Andrew D
Publicado no J Immunother Cancer (2014)

Signaling through OX40 Enhances Anti-tumor Immunity

Por Jensen, Shawn M., Maston, Levi D., Gough, Michael J., Ruby, Carl E., Redmond, William L., Crittenden, Marka, Li, Yuhuan, Puri, Sachin, Poehlein, Christian H., Morris, Nick, Kovacsovics-Bankowski, Magdalena, Moudgil, Tarsem, Twitty, Chris, Walker, Edwin B., Hu, Hong-Ming, Urba, Walter J., Weinberg, Andrew D., Curti, Brendan D, Fox, Bernard A.
Publicado em 2010

OX40 is a potent immune stimulating target in late stage cancer patients

Por Curti, Brendan D., Kovacsovics-Bankowski, Magdalena, Morris, Nicholas, Walker, Edwin, Chisholm, Lana, Floyd, Kevin, Walker, Joshua, Gonzalez, Iliana, Meeuwsen, Tanisha, Fox, Bernard A., Moudgil, Tarsem, Miller, William, Haley, Daniel, Coffey, Todd, Fisher, Brenda, Delanty-Miller, Laurie, Rymarchyk, Nicole, Kelly, Tracy, Crocenzi, Todd, Bernstein, Eric, Sanborn, Rachel, Urba, Walter J., Weinberg, Andrew D.
Publicado em 2013